Biotech XYZ

Biotech XYZ BIOTECH XYZ is a 501(c)(3) nonprofit and registered student organization of Cornell University.

BIOTECH XYZ is excited to announce our first panel event of the year “The AI Diagnosis: How Tech is Transforming Healthc...
02/24/2025

BIOTECH XYZ is excited to announce our first panel event of the year “The AI Diagnosis: How Tech is Transforming Healthcare” with Biolabs@NYULangone!

🗓️ Wednesday, March 5th at 5:30pm
📍Innolabs LIC
📝 Register now: https://lu.ma/fnmgaslg

Our panelists will discuss the innovations, challenges, and the professional avenues on AI in healthcare.
• Rohan Jotwani MD, MBA, Nanette Laitman Scholar in XR/AI, Weill Cornell Medicine
• Olivier Elemento, Director, Institute for Computational Biomedicine, Weill Cornell Medicine
• Mila Orlovsky, Digital Outcomes and AI Strategy, Atlantic Health System
• eMalick Njie, Ph.D, Chief Executive Officer, Ecotone AI

Register now and join us to explore AI in healthcare, hear from experts, and network with fellow professionals passionate about its impact!

On January 13, BIOTECH XYZ co-hosted the Flagship Pioneering Fellowship Program with Tri-I Biotech Club and Weill Cornel...
01/28/2025

On January 13, BIOTECH XYZ co-hosted the Flagship Pioneering Fellowship Program with Tri-I Biotech Club and Weill Cornell Medicine BioVenture eLab. Flagship Pioneering's Fellowship program offers creative life science entrepreneurs the mentorship and network in building biotech start-ups from scratch. Although applications are currently closed, more information about the opportunity be found here: https://www.flagshippioneering.com/join/fellows

Thank you to our speakers Olivia Arnold, PhD (Young), Bharathi Sundaresh, PhD, Ayse Muñiz and thank you to everyone who attended the event!

Our last event of 2024 was "The Diagnostic Odyssey and Beyond: Overcoming Barriers in Rare Genetic Disease Treatment", c...
01/28/2025

Our last event of 2024 was "The Diagnostic Odyssey and Beyond: Overcoming Barriers in Rare Genetic Disease Treatment", co-hosted with Biolabs@NYULangone on November 14. Our moderator, Dr. Glennis Mehra, and our panelists, Elizabeth Brim, Nikul Shukla, and Xiao Peng, discussed the market, legal, and innovative landscape of rare genetic diseases. This evening was filled with insightful discussions about the future direction and challenges of rare genetic diseases.

Thank you Azenta Life Sciences and Covington & Burling LLP for sponsoring this event and thank you to all who attended!

BIOTECH XYZ is delighted to co-host Flagship Pioneering Fellowship Event with Flagship Pioneering and TRIBC!✍ Register N...
01/10/2025

BIOTECH XYZ is delighted to co-host Flagship Pioneering Fellowship Event with Flagship Pioneering and TRIBC!

✍ Register Now: https://lu.ma/ig6po8gv
📅 Monday, January 13th at 6pm
📍 Belfer Research Building (413 E 69th Street, Room 302 ABC)

Flagship Pioneering is a biotechnology company that invents and builds platform companies that change the world, including Moderna, Generate, and Indigo Agriculture. We bring together the greatest scientific minds with entrepreneurial company builders and assemble the capital to allow them to take courageous leaps. The Flagship Pioneering Fellowship is a full-time summer Fellowship (June-August) that provides an unparalleled opportunity for creative, entrepreneurial scientists to immerse themselves in Flagship’s unique approach to inventing and building disruptive life science startups.
Speakers:
• Olivia Arnold, PhD (Young) joined Flagship in 2024 as an Associate with Avak Kahvejian’s team after completing the Flagship Fellowship in 2023.
• Bharathi Sundaresh, PhD joined Flagship in 2024 as an Associate with Lovisa Afzelius’ team after completing the Flagship Fellowship in 2024.
• Ayse Muñiz joined Flagship in 2021 after completing the Flagship Summer Fellowship in 2020.

​This event is sponsored by Weill Cornell Medicine BioVenture eLab.

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Xiao P...
11/08/2024

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Xiao Peng ✨

Xiao Peng joined Montefiore Health System faculty as Assistant Professor in the Division of Genetics, Department of Pediatrics and will be Co-Director of the New York Center for Rare Diseases. Her clinical and research interests synergistically converged on a passionate interest in genetically-driven disorders of blood and immunity. Xiao's lifelong dedication to education means that she has designed and led courses on genetics and immunology and continues to teach medical providers at every level of training at her own and other institutions! Peng will be one of the panelists of "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" on November 14th.

Register now: https://lu.ma/kse6vihv
📅 Thursday, November 14 @ 5:30pm
📍 Biolabs @ NYU Langone

This event is sponsored by Covington & Burling LLP and Biolabs@NYULangone.

✨ ONE WEEK until "The Diagnostic Odyssey and Beyond: Rare Genetic Diseases" on Thursday, November 14 ✨ We will address t...
11/07/2024

✨ ONE WEEK until "The Diagnostic Odyssey and Beyond: Rare Genetic Diseases" on Thursday, November 14 ✨

We will address the major challenges in diagnosing and treating rare genetic diseases, as well as the commercialization of novel therapies.

📝 Register Now: https://lu.ma/kse6vihv
📅 Thursday, November 14, 2024 @ 5:30pm
📍 Biolabs @ NYU Langone

Our Panelists:
- Elizabeth Brim, Associate at Covington & Burling LLP
- Nikul Shukla, Group Product Director of Marketing at Johnson & Johnson
- Xiao Peng, Assistant Professor in the Division of Genetics, Department of Pediatrics Montefiore Health System; Co-Director of the New York Center for Rare Diseases

Our Moderator:
- Dr. Glennis Mehra, Director at Biolabs@NYULangone.

This event is sponsored by Covington & Burling LLP, Biolabs@NYULangone, and Azenta Life Sciences.

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Nikul ...
11/06/2024

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Nikul Shukla ✨

Nikul Shukla, Group Product Director of Marketing at Johnson & Johnson, is passionate about healthcare, rare disease and entrepreneurship and has over 15 years of experience within the pharmaceutical industry. He is leading the physician marketing efforts for a major upcoming launch at Johnson & Johnson and previously launched a pharmaceutical blockbuster product in Schizophrenia and Bipolar Disease. Shukla will be one of the panelists of "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" on November 14th.

Register now: https://lu.ma/kse6vihv
📅 Thursday, November 14 @ 5:30pm
📍 Biolabs @ NYU Langone

This event is sponsored by Covington & Burling LLP and Biolabs@NYULangone.

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Elizab...
11/05/2024

✨ BIOTECH XYZ and Biolabs@NYULangone "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" Panelist Spotlight: Elizabeth Brim ✨

Elizabeth Brim is an associate in the Washington, DC office of Covington & Burling LLP. Brim's practice includes counseling clients on compliance with the complex web of health information privacy laws and regulations, such as HIPAA, the FTC’s Health Breach Notification Rule, state medical and consumer health privacy laws, state consumer privacy laws, and genetic privacy laws. Brim will be one of the panelists of "The Diagnostic Odyssey & Beyond: Rare Genetic Diseases" on November 14th.

Register now: https://lu.ma/kse6vihv
📅 Thursday, November 14 @ 5:30pm
📍 Biolabs @ NYU Langone

This event is sponsored by Covington & Burling LLP and Biolabs@NYULangone.

We are excited to announce our next panelist event "The Diagnostic Odyssey and Beyond: Rare Genetic Diseases" on Novembe...
10/31/2024

We are excited to announce our next panelist event "The Diagnostic Odyssey and Beyond: Rare Genetic Diseases" on November 14! We will explore key challenges in diagnosing and treating rare genetic diseases, focusing on diagnostic delays, healthcare disparities, and regulatory hurdles. Discussions will cover the commercialization of molecular medicines, the balance between scientific innovation and market success, and ensuring equitable access to life-saving treatments. Moderated by Dr. Glennis Mehra, Director at Biolabs@NYULangone.

📝 Register Now! https://lu.ma/kse6vihv
📅 Thursday, November 14, 2024 @ 5:30pm
📍 Biolabs @ NYU Langone

Our Panel:
- Elizabeth Brim, Associate at Covington & Burling LLP
- Nikul Shukla, Group Product Director of Marketing at Johnson & Johnson
- Xiao Peng, Assistant Professor in the Division of Genetics, Department of Pediatrics Montefiore Health System health; Co-Director of the New York Center for Rare Diseases

This event is sponsored by Covington & Burling LLP and Biolabs@NYULangone.

"Curing Costs: How Can We Pay for Gene Therapy" Highlights, hosted by BIOTECH XYZ and Foley & Lardner LLP on September 2...
10/14/2024

"Curing Costs: How Can We Pay for Gene Therapy" Highlights, hosted by BIOTECH XYZ and Foley & Lardner LLP on September 25th.

Our panel on this evening highlighted the affordability, challenges, current condition and future prospects of gene therapy. Thanks to our panelists, Dr. Efrat Eliyahu (Co-Founder of Senex Therapeutics), Andrew Steinsapir (Gene Therapy Program Lead at Deerfield Management; CTO at Apertura Gene Therapy), and Brittany Woods (Associate Director, Strategic and Competitive Insights at Prevail Therapeutics), for their expertise and insights; and to Ellen Horste, PhD for moderating the conversation.

Thanks to all who attended our event! Join our listserv to be updated on our future events: https://biotechxyz.ck.page/903446f6d0

Thanks to Foley & Lardner LLP for sponsoring this event!

🌟 & Foley & Lardner LLP: Curing Costs - How Can We Pay for Gene Therapy? 🌟What an incredible evening last week to kick ...
10/03/2024

🌟 & Foley & Lardner LLP: Curing Costs - How Can We Pay for Gene Therapy? 🌟

What an incredible evening last week to kick off our fall season! Our "Curing Costs: How Can We Pay for Gene Therapy?" event was a huge success, bringing together industry experts, innovators, and a passionate audience to dive deep into one of the most pressing issues in healthcare today.

Thank you to all who attended and participated — we couldn't have asked for a more interactive, inspiring evening!

A big thank you to our brilliant panelists: Dr. Efrat Eliyahu (Co-Founder, Senex Therapeutics), Andrew Steinsapir (Gene Therapy Program Lead, Deerfield Management; CTO, Apertura Gene Therapy), and Brittany Woods (Associate Director, Strategic and Competitive Insights, Prevail Therapeutics, Eli Lilly and Company)

And a special thanks to Ellen Horste, PhD, who moderated the conversation, ensuring that every voice was heard and guiding the discussion through thoughtful, impactful questions. You are an excellent representative for our team, marking our first self-moderating panel successful.

We also want to extend our deepest gratitude to Foley & Lardner LLP, especially Benjamin Bassoff and Evan Hellman, for being such great co-hosts and sponsors, helping us foster lively discussions and meaningful networking opportunities.

💡🔬Stay tuned for more events and discussions from in this season.

Register for BIOTECH XYZ x Foley & Lardner LLP Panel Discussion on “Curing Costs: How Can We Pay for Gene Therapy” happe...
09/20/2024

Register for BIOTECH XYZ x Foley & Lardner LLP Panel Discussion on “Curing Costs: How Can We Pay for Gene Therapy” happening on Wednesday, September 25th!

Registration CLOSES at 5PM Monday, September 23rd.
Register Now! https://lu.ma/b83937nu

​The value of gene therapy drugs to society at large is undeniable: restoring sight to patients with hereditary blindness, hearing to patients with hereditary deafness, mobility to patients with inherited muscular atrophy disorders. The multi-million-dollar price tags, however, are leaving both patients and payers with sticker-shock side effects.

Our panelists:
• Brittany Woods, Associate Director of Strategic and Competitive Insights at Prevail Therapeutics
• Andrew Steinsapir, Director, Gene Therapy Program Lead at Deerfield Management
• Efrat Eliyahu, Assistant Professor with the Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai and Founder of Senex Therapeutics

This event is sponsored by Foley & Lardner LLP.

Address

New York, NY

Website

Alerts

Be the first to know and let us send you an email when Biotech XYZ posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Biotech XYZ:

Shortcuts

Share

Category